C3.ai news

While the stock experienced a significant 40% decline over the past year and the CEO's sale could signal concern, the transaction was non-discretionary under a pre-established plan, not a market-timed decision. The CEO maintains substantial equity holdings, and the company showed positive momentum with 73% quarter-over-quarter booking growth after leadership's return, suggesting recovery potential despite recent underperformance.

C3.ai experienced severe revenue contraction from $108.7M (Q1 2025) to $52.4M (Q2 2026), negative operating margin (-188%), significantly lower market cap ($1.7B), poor gross margin (29.09%), negative P/E ratio (-3.42), and negative EPS (-$3.08). While CEO return and improved bookings suggest potential recovery, current fundamentals remain weak.

Identified as a strong competitor offering broader enterprise and federal AI exposure, indicating competitive strength in the growing AI market.

Mixed results with revenue declining 25.5% YoY indicating business contraction, but the company beat both revenue and EPS estimates. Improved gross margins and significant EPS improvement YoY are positive, but the overall revenue decline and Hold rating suggest cautious outlook. Stock performance (+3% in past month) slightly outperformed broader market decline.

While the company beat EPS estimates, revenues declined significantly year-over-year ($52.38M vs $70.26M), the stock has underperformed the market by 34.8 percentage points YTD, and it carries a Hold rating with mixed estimate revisions, suggesting limited near-term upside.

Fiscal Q4 2026 revenues declined substantially YoY to $51.6M, with company dependent on sales execution and restructuring. Weak performance contrasts sharply with Palantir's momentum.

Company experienced a 35.7% revenue decline to $250.3 million, reported a net loss of $470.4 million with a negative net margin of -187.9%, negative free cash flow of -$190.7 million, and is expected to see further declining sales in fiscal 2027. CEO transition disrupted business momentum.

The company is expected to report significant deterioration across key metrics: increasing per-share losses (up 29.7%), declining total revenues (down 26.8%), sharp drop in professional services revenue (down 69.2%), and compression in gross margins for both business segments. These trends collectively indicate weakening business performance and profitability challenges.

Identified as a relevant competitor offering enterprise AI applications across defense and other industries. Neutral stance reflects competitive positioning without specific performance metrics or outlook.

Significant 35.7% revenue decline in FY2026, substantial net loss of $470.4 million, negative free cash flow of $190.7 million, high customer concentration risk, and recent CEO transition create uncertainty. While the company has a strong balance sheet with zero debt, it must prove it can return to growth.

Company is experiencing severe financial distress with 35.7% revenue decline, $470.4M net loss, $1.8B accumulated deficit, negative free cash flow of $190.7M, and CEO describing sales as 'unspeakably horrible.' Workforce reduction of approximately one-third and ongoing sales reorganization indicate significant turnaround challenges with high execution risk.

Company experiencing severe financial distress with 35.7% revenue decline, $470.4M net loss, negative $190.7M free cash flow, $1.8B accumulated deficit, heavy customer concentration risk, and CEO transition uncertainty. Forward P/E of 25.6x indicates expensive valuation relative to poor fundamentals.

While the stock has experienced a severe 66% decline over the past year and revenue fell significantly ($389.1M to $250.3M), the CEO's sale was non-discretionary and part of a pre-planned trading arrangement, not indicative of loss of confidence. Siebel's return as CEO and substantial retained stake suggest potential for recovery, warranting a neutral rather than negative assessment.

The company faces significant headwinds including a 55.3% one-year stock price decline, sharp revenue contraction (from $389.1M to $250.3M), and doubled net losses ($470.4M vs $288.7M). While the CFO's sale itself is not concerning (tax-related), it reflects a company in distress. Positive catalysts (CEO return, Shell partnership) provide some hope but are insufficient to offset current fundamental challenges.

Beat loss estimates (33 cents vs 37 cents) with revenue beat at $51.6M vs $50.24M

Company beat both earnings and revenue estimates, stock jumped 11% in after-hours trading, and CEO expressed strong confidence in restructuring and execution plan. However, sentiment is tempered by acknowledgment of past poor sales performance and fiscal 2027 guidance slightly below analyst expectations.

Revenue projected to decline from $389M to $251M (fiscal 2025-2028), net losses widened to $289M, shrinking gross margins, major sales team restructuring, and losing ground to competitors. Limited upside potential despite seemingly low valuation.

Stock declined 5.59% on the day and 62.46% over 12 months. While revenue met guidance and cost-cutting measures were implemented, lower-than-expected bookings and a GAAP operating loss of $121.2M indicate ongoing profitability challenges. The analyst consensus rating is 'Hold' with a price target of $8.57, below current trading levels.

As an AI infrastructure provider, the company benefits from enterprise-scale AI adoption rather than being threatened by it; positioned to thrive as AI takes off.

Consensus Moderate Sell rating with multiple explicit Sell ratings. true subscription revenue fell 16% YoY, total revenue dropped 46% YoY, and management cut fiscal 2026 guidance by $51 million. Stock down 55% YTD with fair value estimated at $6 per share versus current $8.50 trading price. Company exploring strategic alternatives including potential sale.

Severe revenue collapse (46% decline), significant quarterly losses ($133.4M), founder departure disrupting sales, projected continued revenue declines (36% in FY2026, 10% in FY2027), and analyst concerns about further downside despite low valuation multiples.

The company faces significant headwinds including a 55% stock decline over one year, a $133.4 million quarterly GAAP net loss, negative operating margins, and ongoing restructuring efforts. While the company has a strong cash position ($621.9 million) and is shifting toward a recurring subscription model (90% of revenue), profitability remains a major concern and execution risk is high.

Smaller unprofitable AI software company at risk of becoming irrelevant as hyperscalers launch competing first-party AI services

Identified as a loser facing marginalization. Experiencing slower growth as generative AI platforms and big cloud providers offer more cost-effective, ready-to-use solutions that outperform C3.ai's software modules.

The underlying stock has experienced severe declines of 50% over the past year and 70% from its 52-week high, creating material idiosyncratic risk for the ETF that focuses exclusively on this company.

Despite recent bearish price action and downward trend to 52-week lows, the article highlights a significant bullish signal from sophisticated institutional traders through massive call option buying (60,000 contracts). The combination of high short interest (38% of float), low days to cover (6.3 days), and concentrated call buying suggests potential for a near-term rally and short squeeze, indicating forward-looking optimism from smart money despite current negative fundamentals.

The company faces multiple headwinds: 59.9% stock decline over the past year, significant revenue drop in Q3 (from $98.8M to $53.3M year-over-year), CEO departure due to health reasons, and broader AI sector concerns about a potential bubble. While the CFO's sale itself is not alarming (tax-related), the underlying business fundamentals and market conditions warrant a negative outlook. Analysts recommend waiting for revenue growth recovery before considering investment.

The company is experiencing significant operational and financial challenges including a 62% one-year stock price decline, substantial revenue drop (46% decrease year-over-year), recent CEO departure due to health reasons, and a 52-week low of $7.72. While the insider sale itself is not alarming due to the pre-planned trading arrangement, the underlying company fundamentals and market performance are weak. The article recommends investors wait for the new CEO to prove revenue growth capability before making investment decisions.

The stock has plummeted 36% in 2026 with multiple declines reported (27.8% in February, 33% year-to-date). The company faces headwinds from increasing competition, leadership disruption due to CEO resignation, and disrupted growth trajectory. The article's framing as 'falling knife to avoid' suggests significant downside risk.

Company significantly missed revenue expectations ($53.26M vs $76M consensus), reported larger-than-expected losses, announced 26% workforce reduction, and provided weak forward guidance with declining Q4 revenue expectations, indicating fundamental business deterioration.

Despite announcing a strategic partnership with Vonage, C3.ai shares declined 6.32% and are trading near 52-week lows. Technical analysis shows pronounced downtrend, bearish MACD signals, death cross from March 2025, and weak momentum score (2.48). Stock is significantly below all key moving averages indicating strong bearish momentum.

Mentioned as a competitor in the AI robotics space but operates a different business model focused on enterprise AI software rather than autonomous delivery, with no direct performance implications discussed.

C3.ai is expected to report a quarterly loss of $0.26 per share with revenues declining 26.8% year-over-year. The consensus EPS estimate has remained unchanged over the last 30 days, indicating no improvement in outlook.

Identified as a digitally native data analytics competitor that could challenge Palantir's first-mover advantage in the AI-powered data analytics market.

Announced 26% workforce reduction as part of restructuring, indicating operational challenges and cost-cutting measures.